These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21809143)

  • 1. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
    Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
    Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects.
    Amann BL; Pogarell O; Mergl R; Juckel G; Grunze H; Mulert C; Hegerl U
    Hum Psychopharmacol; 2003 Dec; 18(8):641-6. PubMed ID: 14696024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
    Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
    Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
    Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
    JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk of haloperidol vs. atypical anti-psychotic drugs in schizophrenia treatment].
    Dobrin I; Dobrin RP; Chele G; Stefănescu C; Knieling A; Chiriţă R
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):658-61. PubMed ID: 21243790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
    Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
    J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
    Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
    Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abuse and misuse of second-generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database.
    Roy S; Charreteur R; Peries M; Kheloufi F; Eiden C; Nagot N; Donnadieu-Rigole H; Micallef J; Peyrière H
    Br J Clin Pharmacol; 2022 Oct; 88(10):4646-4653. PubMed ID: 35633029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
    Rossom RC; Rector TS; Lederle FA; Dysken MW
    J Am Geriatr Soc; 2010 Jun; 58(6):1027-34. PubMed ID: 20487081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?
    Meyer-Massetti C; Cheng CM; Sharpe BA; Meier CR; Guglielmo BJ
    J Hosp Med; 2010 Apr; 5(4):E8-16. PubMed ID: 20394022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
    Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
    Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery : A Nationwide Cohort Study.
    Kim DH; Lee SB; Park CM; Levin R; Metzger E; Bateman BT; Ely EW; Pandharipande PP; Pisani MA; Jones RN; Marcantonio ER; Inouye SK
    Ann Intern Med; 2023 Sep; 176(9):1153-1162. PubMed ID: 37665998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
    Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
    Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population.
    Duncan EJ; Woolson SL; Hamer RM; Dunlop BW
    Int Clin Psychopharmacol; 2009 Jul; 24(4):204-13. PubMed ID: 19494785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based cohort study in Denmark.
    Pasternak B; Svanström H; Ranthe MF; Melbye M; Hviid A
    CNS Drugs; 2014 Oct; 28(10):963-73. PubMed ID: 24895158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.